Search

Displaying results 7391 - 7400 of 10000 in total
  1. Drug

    Vonifimod

    go.drugbank.com/drugs/DB21633
    Experimental

    The usage of the INN stem '-imod' in the name indicates that Vonifimod is a immunomodulator, both stimulant/suppressive and stimulant. Vonifimod has a monoisotopic molecular weight of 326.27 Da.

  2. Drug

    Aneratrigine

    go.drugbank.com/drugs/DB21639
    Experimental

    The usage of the INN stem '-trigine' in the name indicates that Aneratrigine is a sodium channel blocker, signal transduction modulator. Aneratrigine has a monoisotopic molecular weight of 487.07 Da.

  3. Drug

    Resigratinib

    go.drugbank.com/drugs/DB21664
    Experimental

    The usage of the INN stem '-gratinib' in the name indicates that Resigratinib is a fibroblast growth factor receptor (FGFR) inhibitor. Resigratinib has a monoisotopic molecular weight of 523.21 Da.

  4. Drug

    Lirodegimod

    go.drugbank.com/drugs/DB21675
    Experimental

    The usage of the INN stem '-imod' in the name indicates that Lirodegimod is a immunomodulator, both stimulant/suppressive and stimulant. Lirodegimod has a monoisotopic molecular weight of 1256.45 Da.

  5. Drug

    Segatroxaban

    go.drugbank.com/drugs/DB21678
    Experimental

    The usage of the INN stem '-xaban' in the name indicates that Segatroxaban is a blood coagulation factor XA​ inhibitor, antithrombotic. Segatroxaban has a monoisotopic molecular weight of 567.14 Da.

  6. Drug

    Fanregratinib

    go.drugbank.com/drugs/DB21688
    Experimental

    The usage of the INN stem '-gratinib' in the name indicates that Fanregratinib is a fibroblast growth factor receptor (FGFR) inhibitor. Fanregratinib has a monoisotopic molecular weight of 508.24 Da.

  7. Drug

    Ilantimod

    go.drugbank.com/drugs/DB21742
    Experimental

    The usage of the INN stem '-imod' in the name indicates that Ilantimod is a immunomodulator, both stimulant/suppressive and stimulant. Ilantimod has a monoisotopic molecular weight of 387.11 Da.

  8. Drug

    Lefradafiban

    go.drugbank.com/drugs/DB04863
    Investigational

    Lefradafiban is an oral platelet glycoprotein IIb/IIIa receptor antagonist being investigated in the treatment of angina.

  9. Drug

    NS-2359

    go.drugbank.com/drugs/DB05805
    Investigational

    This mode of action is expected to produce an optimal reduction in all disease symptoms and the possibility of an earlier onset of action compared to antidepressants already on the market. … Enhancing the function of the three neurotransmitters serotonin, noradrenalin and dopamine, NS2359 has a desired "triple-mode-of-action".

  10. Drug

    Solcitinib

    go.drugbank.com/drugs/DB19856
    Investigational

    Solcitinib has a monoisotopic molecular weight of 389.19 Da. … The usage of the INN stem '-citinib' in the name indicates that Solcitinib is a Janus kinase inhibitor.